Anupam Rasayan: There's a slowdown in agro segment but better traction in pharma, monomers & personal care: Anupam Rasayan management
Thakkar and Agrawal foresee revenue growth in FY25, stable margins, and positive long-term outlook. Anupam Rasayan's strategic investments, pass-through pricing, and market performance drive the company's growth trajectory. Thakkar says: " Japan is one geography that has really worked well for us and we are seeing a lot of buoyancy there. "
Source: indiatimes.com
